Skip to content
Dose Brief
Menu

Provider review

KairoRx review

By · Updated

KairoRx publishes introductory, renewal and quarterly GLP-1 prices, but the semaglutide quarterly offer is not cheaper than its listed monthly rate. Brand-name access fees exclude the medication.

Not rated. This review examines published program information; it is not a firsthand treatment review.

Visit KairoRx (opens in a new tab)Compare rated providers

At a glance

Semaglutide
$49 first month, then $199/month; quarterly offer $747
Tirzepatide
$99 first month, then $349/month; quarterly offer $897
Availability
Confirm your state and product; a complete treatment-specific state list was not established.
Treatment formats
Compounded semaglutide/tirzepatide injections; separate branded Ozempic and Zepbound access programs.

Quarterly plans require a three-month payment. Branded Ozempic/Zepbound access is $65/month plus medication.

The quarterly label is not enough to establish value

KairoRx lists compounded semaglutide at $49 for the first month, then $199 monthly. Its quarterly card lists $747, or $249 per month, even while calling that option best value. On the displayed numbers, that quarterly equivalent is higher than the regular monthly rate. Ask what additional service or pricing protection, if any, explains the difference.

Tirzepatide has a different comparison: $99 for the first month, then $349 monthly, versus $897 per quarter, or $299 per month. The quarterly amount is a larger single commitment. Confirm which promotion applies and what the following charge will be.

The $65 brand offer excludes the prescription cost

Ozempic and Zepbound pages list $65 monthly access fees for provider review, monitoring and support, with medication billed separately by the pharmacy. A $65 access plan cannot be compared directly with a compound offer that includes medication. Obtain both the access charge and the pharmacy quote before deciding.

Approval and refund rules have separate stages

The FAQ says assessment alone does not create a provider-patient relationship or guarantee a prescription and that charges begin only after provider approval. The refund policy offers a full refund within 14 days of the first charge only if the pharmacy has not prepared the medication. Prepared or shipped medication is not refundable under that policy; fees for completed provider reviews are also treated separately.

Confirm the care team before paying

KairoRx describes a network of licensed providers and pharmacy partners, but the reviewed pages do not identify a prescribing medical group or individual dispensing pharmacy. Ask for those names, their contact details and confirmation that the selected treatment is available in your state. The brand-name and compounded programs have different cost structures, so the written plan should identify which route you are buying.

What stands out

  • Clearly separates introductory and renewal prices
  • Brand pages disclose medication costs are separate

What to check

  • Semaglutide quarterly value label conflicts with displayed monthly comparison
  • Medical group and pharmacy names remain unconfirmed

Sources and review scope

Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.